Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-tissue regeneration

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 75, Issue 1, 2005, Pages 34-41

  Kim, Hae Won ^a   Lee, Eun Jung ^a   Jun, In Kook ^a   Kim, Hyoun Ee ^a   Knowles, Jonathan C ^b  

^a Seoul National University   (South Korea)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Degradation; Drug release; Glass dissolution; Hard tissue regenerative; Phosphate glass (P glass); Polycaprolactone

Indexed keywords

COMPOSITE MATERIALS; COMPOSITION; DEGRADATION; DISSOLUTION; DRUG PRODUCTS; PHOSPHATES; SOLVENT EXTRACTION; TISSUE;

DRUG RELEASE; GLASS DISSOLUTION; HARD-TISSUE REGENERATIVE; PHOSPHATE GLASS (P-GLASS); POLYCAPROLACTONE;

BIOMATERIALS;

ANTIBIOTIC AGENT; CALCIUM OXIDE; GLASS; ION; PHOSPHATE; PHOSPHATE GLASS; PHOSPHORUS PENTOXIDE; POLYCAPROLACTONE; SODIUM DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CHEMICAL COMPOSITION; COMPOSITE MATERIAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DILUTION; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HEAT TREATMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; SOLVENT EXTRACTION; THERMAL PRESSING; TISSUE REGENERATION; WOUND HEALING;

BIOCOMPATIBLE MATERIALS; BONE REGENERATION; CALCIUM; CELL LINE; CELL SURVIVAL; COMPOSITE RESINS; CULTURE MEDIA; DRUG DELIVERY SYSTEMS; GLASS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PHOSPHATES; POLYESTERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WOUND HEALING;

EID: 25844462358     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30223     Document Type: Article

References (22)

1. Bauer TW, Muschler GF. Bone graft materials: an overview of the basic science. Clin Orthop Relat Res 2000;371:10-27.
2. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508-1514.
3. Smith KL, Schimpf ME, Thompson KE. Bioerodible polymers for delivery of macromolecules. Adv Drug Deliv Res 1990;4: 343-357.
4. Kimura Y. Biodegradable polymers. In: Tsuruta T, editor. Biomedical applications of polymeric materials. Boca Raton, FL: CRC Press; 1993. p 163-189.
5. Li S, Vert M. Degradable polymers: Principles and applications. London: Chapman and Hall; 1995.
6. Pitt CG. Poly(ε-caprolactone) and its copolymers. In: Chasin M, Langer R, editors. Biodegradable polymers as drug delivery systems. New York: Marcel Dekker; 1990. p 71-120.
7. Huang MH, Li S, Hutmacher DW, Schantz JT, Vacanti CA, Braud C, Vert M. Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of ε-caprolactone in the presence of poly(ethylene glycol). J Biomed Mater Res 2004;69A:417-427
8. Zhu ZX, Xiong CD, Zhang LL, Deng XM. Synthesis and characterization of poly(caprolactone)-poly(ethylene glycol) block copolymers. J Polym Sci A 1997;35:709-714.
9. Knowles JC. Phosphate based glasses for biomedical applications. J Mater Chem 2003;13:2395-2401.
10. Franks K, Abrahams I, Knowles JC. Development of soluble glasses for biomedical use. Part I: in vitro solubility measurement. J Mater Sci Mater Med 2000;11:609-614.
11. Salih V, Franks K, James M, Hastings GW, Knowles JC. Development of soluble glasses for biomedical use. Part II: The biological response of human osteoblast cell lines to phosphate-based soluble glasses. J Mater Sci Mater Med 2000;11:615-620.
12. Kim HW, Knowles JC, Kim HE. Development of hydroxyapatite bone scaffold for controlled drug release via poly(ε-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res Part B: Appl Biomater 2004;70B:240-249.
13. Kim HW, Knowles JC, Kim HE. Effect of biphasic calcium phosphates on drug release and biological and mechanical properties of poly(ε-caprolactone) composite membranes. J Biomed Mater Res 2004;70A:467-479.
14. Kikuchi M, Koyama Y, Yamada T, Imamura Y, Okada T, Noriaki S, Akita K, Takakuda K, Junzo T. Development of guided bone regeneration membrane composed of β-tricalcium phosphate and poly(L-lactide-co-glycolide-co-ε- caprolactone) composites. Biomaterials 2004;25:5979-86.
15. Ural E, Kesenci K, Fambri L, Migliaresi C, Piskin E. Poly(D,L-lactide/- caprolactone)/hydroxyapatite composites. Biomaterials 2000;21:2147-154.
16. Durucan C, Brown PW. Low temperature formation of calcium-deficient hydroxyapatite-PLA/PLGA composites. J Biomed Mater Res 2000;51:717-725.
17. Liao SS, Cui FZ, Zhang W, Feng QL. Hierarchically biomimetic bone scaffold materials: nano-HA/collagen/PLA composite. J Biomed Mater Res Part B: Appl Biomater 2004;69B:158-165.
18. Lu HH, El-Amin SF, Scott KD, Laurencin CT. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro. J Biomed Mater Res 2003;64A:465-474.
19. Blaker JJ, Gough JE, Maquet V, Notingher I, Boccaccini AR. In vitro evaluation of novel bioactive composites based on Bioglass®-filled polylactide foams for bone tissue engineering scaffolds. J Biomed Mater Res 2003;67A:1401-1411.
20. Lowry KJ, Hamson KR, Bear L, Peng YB, Calaluce RM Evans ML, Anglen JO, Allen WC. Polycaprolactone/glass bioabsorbable implant in a rabbit humerus fracture model. J Biomed Mater Res 1997;36:536-541.
21. Kim HW, George G, Knowles JC, Koh YH, Kim HE. Calcium phosphate and glass composite coatings on zirconia for enhanced biocompatibility. Biomaterials 2004;25:4203-4213.
22. Willson TM, Charifson PS, Baxter AD, Geddie NG. Bone targeted drugs 1. Identification of heterocycles with hydroxyapatite affinity. Bioorg Med Chem Lett 1996;6: 1043-1046.